Open Access
Copyright: The authors. This article is an open access
article licensed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0) which permits unrestricted use,
distribution and reproduction in any medium, provided the work is properly
cited.
Case Report
8.
Hypertrophic cardiomyopathy and their therapeutic
management in a Lhasa apso dog -
Deepak K. Kashyap, Shailendra K. Tiwari, Govina
Dewangan, Devesh K. Giri
Vet World. 2012; 5(8): 493-494
doi:
10.5455/vetworld.2012.
493-494
Abstract
Case
history and observation: A male, 3 years old
Lhasa Apso dog was presented with the history of
haematemesis, dehydration, exercise intolerance,
poor appetite, lethargy, cough, seizures and syncope
for more than 3 weeks. Lateral roentgenogram
revealed enlarged heart. Based on radiographic
examination alongwith history of seizures and
syncope the condition was diagnosed as hypertrophic
cardiomyopathy. Treatment: The dog was
treated with oral diltiazem @ 1.5 mg/kg body weight,
ramipril @ 0.5 mg/kg body weight and frusemide @ 2
mg/kg body weight orally along with fluid therapy.
Clinical improvement was noticed from third day.
Improvement in appetite and physical activity with
complete alleviation of clinical signs was observed
by continued diltiazem (1.5 mg/kg, orally) and
ramipril (0.5 mg/kg).
Result: It was reported
that the dog continued to improve and became much
brighter and active over next 25 days. Post
treatment radiograph showed nearly normal size of
the heart suggestive of clinical recovery.
Conclusion: Thus it is conclude that
hypertrophic cardiomyopathy can be comfortably
managed by medicinal therapy in canines.
Keywords: Hypertrophic Cardiomyopathy, Haematemesis, Seizures,
Syncope.
